Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Trial Result Tables

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton May 02, 2023 6:32pm

127 Views

Post# 35426291

RE:RE:Trial Result Tables

Yes it was a typo - it should be 450. Thanks Infinity.

Infinity wrote: Thanks Eoga,
This presentation has way more clarity. I believe the last column on the right has a Typo, should read 450 days instead of 350 days?

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market